vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and NorthEast Community Bancorp, Inc. (NECB). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $26.4M, roughly 1.7× NorthEast Community Bancorp, Inc.). NorthEast Community Bancorp, Inc. runs the higher net margin — 40.9% vs -19.9%, a 60.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 3.9%). NorthEast Community Bancorp, Inc. produced more free cash flow last quarter ($50.8M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 1.8%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
NorthEast Community Bancorp, Inc. (MD) is a U.S.-based bank holding company operating primarily in the Mid-Atlantic region. It provides a comprehensive suite of consumer and commercial banking services, including deposit products, mortgage loans, small business financing, and wealth management solutions to individual and local enterprise clients.
ABCL vs NECB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $26.4M |
| Net Profit | $-8.9M | $10.8M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 59.0% |
| Net Margin | -19.9% | 40.9% |
| Revenue YoY | 788.4% | 3.9% |
| Net Profit YoY | 73.9% | 5.8% |
| EPS (diluted) | $-0.03 | $0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $26.4M | ||
| Q3 25 | $9.0M | $27.0M | ||
| Q2 25 | $17.1M | $25.9M | ||
| Q1 25 | $4.2M | $25.5M | ||
| Q4 24 | $5.0M | $25.4M | ||
| Q3 24 | $6.5M | $27.6M | ||
| Q2 24 | $7.3M | $27.0M | ||
| Q1 24 | $10.0M | $25.5M |
| Q4 25 | $-8.9M | $10.8M | ||
| Q3 25 | $-57.1M | $11.9M | ||
| Q2 25 | $-34.7M | $11.2M | ||
| Q1 25 | $-45.6M | $10.6M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $-51.1M | $12.7M | ||
| Q2 24 | $-36.9M | $12.8M | ||
| Q1 24 | $-40.6M | $11.4M |
| Q4 25 | -63.7% | 59.0% | ||
| Q3 25 | -851.8% | 61.6% | ||
| Q2 25 | -290.2% | 59.5% | ||
| Q1 25 | -1479.6% | 57.4% | ||
| Q4 24 | — | 57.0% | ||
| Q3 24 | -1439.4% | 63.6% | ||
| Q2 24 | -1276.2% | 65.6% | ||
| Q1 24 | -551.5% | 62.7% |
| Q4 25 | -19.9% | 40.9% | ||
| Q3 25 | -637.8% | 44.0% | ||
| Q2 25 | -203.3% | 43.1% | ||
| Q1 25 | -1077.2% | 41.4% | ||
| Q4 24 | — | 40.1% | ||
| Q3 24 | -785.4% | 45.9% | ||
| Q2 24 | -504.3% | 47.5% | ||
| Q1 24 | -408.0% | 44.5% |
| Q4 25 | $-0.03 | $0.78 | ||
| Q3 25 | $-0.19 | $0.87 | ||
| Q2 25 | $-0.12 | $0.82 | ||
| Q1 25 | $-0.15 | $0.78 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | $-0.17 | $0.95 | ||
| Q2 24 | $-0.13 | $0.97 | ||
| Q1 24 | $-0.14 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $81.2M |
| Total DebtLower is stronger | — | $70.0M |
| Stockholders' EquityBook value | $966.9M | $351.7M |
| Total Assets | $1.4B | $2.1B |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $81.2M | ||
| Q3 25 | $83.2M | $64.3M | ||
| Q2 25 | $92.4M | $59.4M | ||
| Q1 25 | $159.3M | $89.5M | ||
| Q4 24 | $156.3M | $78.3M | ||
| Q3 24 | $126.6M | $97.8M | ||
| Q2 24 | $148.3M | $113.9M | ||
| Q1 24 | $123.6M | $107.4M |
| Q4 25 | — | $70.0M | ||
| Q3 25 | — | $170.0M | ||
| Q2 25 | — | $135.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $47.0M | ||
| Q1 24 | — | $47.0M |
| Q4 25 | $966.9M | $351.7M | ||
| Q3 25 | $964.0M | $344.0M | ||
| Q2 25 | $1.0B | $336.7M | ||
| Q1 25 | $1.0B | $327.2M | ||
| Q4 24 | $1.1B | $318.3M | ||
| Q3 24 | $1.1B | $309.6M | ||
| Q2 24 | $1.1B | $300.0M | ||
| Q1 24 | $1.1B | $288.9M |
| Q4 25 | $1.4B | $2.1B | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | $1.4B | $2.0B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | $1.4B | $2.0B | ||
| Q3 24 | $1.4B | $2.0B | ||
| Q2 24 | $1.4B | $1.9B | ||
| Q1 24 | $1.5B | $1.9B |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $52.6M |
| Free Cash FlowOCF − Capex | $-44.6M | $50.8M |
| FCF MarginFCF / Revenue | -99.4% | 192.3% |
| Capex IntensityCapex / Revenue | 21.9% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 4.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $89.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $52.6M | ||
| Q3 25 | $-52.6M | $14.1M | ||
| Q2 25 | $-32.4M | $15.6M | ||
| Q1 25 | $-11.6M | $10.9M | ||
| Q4 24 | $-108.6M | $48.7M | ||
| Q3 24 | $-28.9M | $14.4M | ||
| Q2 24 | $-30.0M | $11.1M | ||
| Q1 24 | $-41.7M | $12.9M |
| Q4 25 | $-44.6M | $50.8M | ||
| Q3 25 | $-61.5M | $13.6M | ||
| Q2 25 | $-45.8M | $14.9M | ||
| Q1 25 | $-22.2M | $10.6M | ||
| Q4 24 | $-187.0M | $48.2M | ||
| Q3 24 | $-47.4M | $14.2M | ||
| Q2 24 | $-50.1M | $11.0M | ||
| Q1 24 | $-65.8M | $12.8M |
| Q4 25 | -99.4% | 192.3% | ||
| Q3 25 | -687.0% | 50.5% | ||
| Q2 25 | -267.9% | 57.3% | ||
| Q1 25 | -524.0% | 41.4% | ||
| Q4 24 | -3702.8% | 189.3% | ||
| Q3 24 | -728.4% | 51.5% | ||
| Q2 24 | -683.8% | 40.8% | ||
| Q1 24 | -661.5% | 50.3% |
| Q4 25 | 21.9% | 6.6% | ||
| Q3 25 | 99.7% | 1.6% | ||
| Q2 25 | 78.2% | 2.9% | ||
| Q1 25 | 251.1% | 1.5% | ||
| Q4 24 | 1552.7% | 2.0% | ||
| Q3 24 | 284.6% | 0.6% | ||
| Q2 24 | 274.6% | 0.5% | ||
| Q1 24 | 242.5% | 0.3% |
| Q4 25 | — | 4.86× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | — | 1.40× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | — | 4.77× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 0.87× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
